Ambroxol hydrochloride

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Glucocerebrosidase ( GBA1) mutations are the major genetic risk factor for Parkinson’s Disease (PD). The pathogenic mechanism is still unclear, but alterations in lysosomal-autophagy processes are implicated due to reduction of mutated glucocerebrosidase (GCase) in lysosomes. Wild-type GCase activity is also decreased in sporadic PD brains. Small molecule chaperones that increase lysosomal GCase activity have potential to be disease-modifying therapies for GBA1-associated and sporadic PD. Therefore we have used mouse cortical neurons to explore the effects of the chaperone ambroxol. This chaperone increased wild-type GCase mRNA, protein levels and activity, as well as increasing other lysosomal enzymes and LIMP2, the GCase transporter. Transcription factor EB (TFEB), the master regulator of the CLEAR pathway involved in lysosomal biogenesis was also increased upon ambroxol treatment. Moreover, we found macroautophagy flux blocked and exocytosis increased in neurons treated with ambroxol. We suggest that ambroxol is blocking autophagy and driving cargo towards the secretory pathway. Mitochondria content was also found to be increased by ambroxol ...

Ambroxol Syrup Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency. Beside these, Ambroxol also exhibits anti-oxidant activity. Long-term use is possible because of the good tolerability of the preparation. Uses • • Acute and chronic diseases of respiratory tracts associated with viscid mucus including acute and chronic bronchitis • • Productive cough • • Inflammatory diseases of Rhinopharyngeal tract (e.g. Laryngitis, Pharyngitis, Sinusitis and Rhinitis) associated with viscid mucus • • Asthmatic bronchitis, Bronchial asthma with difficult departure of mucus • • Bronchiectasis • • Chronic pneumonia. Ambroxol is also used to associated treatment for these conditions: Airway secretion clearance therapy How Ambroxol works Ambroxol is a mucolytic agent. Excessive Nitric oxide (NO) is associated with inflammatory and some other disturbances of...

• Articles & Issues • Current Release • Previous Release • Browse by Specialty • Channels • Breast Cancer • Gastroenterology and Hepatology • HIV/AIDS • Infectious Diseases • Oncology • Radiology • For Authors • Information for Authors • Criteria For Acceptance • Pre-Submission Checklist • Author Services • Medicine FAQ • Author Advice Gallery • Choosing Medicine • Lippincott® Preprints • For Reviewers • Guidelines and Information • CME For Reviewers • Peer Review Training • Journal Info • About the Journal • Editorial Board - Medicine • Rights and Permissions • Submit Research Article: Systematic Review and Meta-Analysis The application of ambroxol hydrochloride combined with fiberoptic bronchoscopy in elderly patients with severe pneumonia A meta-analysis and systematic review Tang, Haowei MD; Yuan, Zhi MD ∗; Li, JingJie MD; Wang, Qun MD; Fan, Weijie MD Editor(s): Mayr., Johannes Department of Respiratory Medicine, Fenghua District People's Hospital, China. ∗Correspondence: Zhi Yuan, No. 36, Gongyuan Road, Fenghua City, Ningbo City 315500, Zhejiang Province, China (e-mail: [emailprotected]). Abbreviations: CI = confidence interval, MD = mean difference, OR = odds ratio, RCT = randomized controlled trial. How to cite this article: Tang H, Yuan Z, Li J, Wang Q, Fan W. The application of ambroxol hydrochloride combined with fiberoptic bronchoscopy in elderly patients with severe pneumonia: a meta-analysis and systematic review. Medicine. 2022;101:4(e28535). Ethics appr...